Mastodon

Artro-Active Pitanie sustavov (Tablets) Instructions for Use

Marketing Authorization Holder

DIOD Plant of Environmental Technology and Ecopitanie, PJSC (Russia)

Dosage Form

Bottle OTC Icon Artro-Active Pitanie sustavov Tablets

Dosage Form, Packaging, and Product Composition

Composition: chondroitin sulfate, glucosamine sulfate, collagen hydrolysate, frankincense tree resin extract, microcrystalline cellulose, natural identical flavoring “Cream”, calcium stearate.

1 tab.
Chondroitin sulfate 100.0 mg
Glucosamine sulfate 125.0 mg
Boswellic acids 20.0 mg

Dosage form and packaging
Tablets 0.5 g.

Therapeutic Category

Dietary supplement for maintaining musculoskeletal function

Scope of Application

Of the Artro-Active Pitanie sustavov product

Recommended as a dietary supplement – a source of glucosamine sulfate and chondroitin sulfate.

Indications

Use this dietary supplement as a source of specific nutrients to support musculoskeletal health.

  • Utilize to provide the body with glucosamine sulfate and chondroitin sulfate, which are building blocks for joint tissues.
  • Employ as a supplementary source of these compounds for individuals whose dietary intake may be insufficient.

ICD codes

ICD-10 code Indication
E63.8 Other specified types of nutritional deficiency
ICD-11 code Indication
5B7Z Malnutrition, unspecified
8D40.0 Encephalopathy due to nutritional deficiency

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Take orally with meals and a full glass of water to improve tolerability.

For adults, administer 2 tablets twice daily during the first week of therapy.

For subsequent use from weeks two through five, reduce the dosage to 1 tablet twice daily.

Complete the full course of administration, which lasts for 5 weeks in total.

Adverse Reactions

Monitor for gastrointestinal disturbances, including epigastric pain, flatulence, diarrhea, or constipation.

Discontinue use immediately and consult a physician if any signs of an allergic reaction occur, such as skin rash, pruritus, or urticaria.

Report any other unexpected effects experienced while taking the supplement.

Drug Interactions

Exercise caution with concurrent use of anticoagulant or antiplatelet medications (e.g., warfarin, aspirin) due to a potential increased risk of bleeding.

Consult a healthcare professional before combining this supplement with any prescription drugs, as chondroitin is structurally similar to heparin.

Be aware that the potential for interactions with other agents has not been fully studied.

Contraindications

Do not use under the following conditions.

  • Do not administer to individuals with a known hypersensitivity to any component of the supplement, including chondroitin, glucosamine, or Boswellia extract.
  • Avoid use during pregnancy due to a lack of safety data.
  • Avoid use throughout the period of breastfeeding.

Seek advice from a doctor prior to initiating use.

Overdose

In case of accidental ingestion of a significantly larger than recommended dose, seek immediate medical attention or contact a Poison Control Center.

Be aware that symptoms of overdose are likely to be an extension of the adverse reactions, primarily severe gastrointestinal upset.

Provide the medical professional with the product packaging and information about the quantity consumed.

Dispensing Status

Available to the public through pharmacy chains and specialized stores, departments of the retail network.

Storage Conditions

Store in a dry place at a temperature not exceeding 25°C (77°F).

Shelf Life

Shelf life – 2 years.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS